Stocks · News reference
Morgan Stanley Maintains Overweight on KLA, Lowers Price Target to $227
Morgan Stanley analyst Shane Brett maintains KLA (NASDAQ:KLAC) with a Overweight and lowers the price target from $253 to $227.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Teradyne Expands Memory Test Portfolio: Can It Beat KLAC & COHU?
Teradyne's memory revenues hit a record $212M in Q2 2026, marking its third consecutive quarter above $200M, driven by strong demand for HBM, DRAM, and NAND testing. The company launched Magnum E2, a next-generation memory test system supporting advanced interfaces like LPDDR6, DDR6, GDDR7, and NAND. Management expects the 2026 memory test TAM to grow over 40% compared to 2025. However, TER stock trades at a premium valuation and faces competition from KLA and Cohu.
Billionaire Investor Dan Loeb’s Third Point Exited 5 Chip Stocks Last Quarter — Here’s How They’re Performing Today
Dan Loeb’s Third Point exited five semiconductor holdings in Q2, while several of the stocks have since gained.